← Leaderboards
Dorothy E Vatner
Pennsylvania State Univ Hershey Med Ctr
$15,244,107
Attributed
$16,349,217
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$37,661,046 · 18
By mechanism
P01$25,260,564 · 6
R01$10,127,270 · 8
R44$1,702,117 · 2
R21$437,250 · 1
R41$133,845 · 1
Top collaborators
- Stephen F Vatner4 shared
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacHeartChronicMyocardial IschemiaHeart FailureMediatingResponseSignal TransductionHeart DiseasesBaseAdverse EffectsFamily SuidaeCoronaryMyocardial InfarctionMuscle CellsCardiac MyocytesMyocardialKnockout MiceApoptosisIschemiaGenesPathway InteractionsStressAdenylyl Cyclase Type V
Grant awards (64)
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk$564,480
R01 · FY2020 · HL · contact PI
Adenylyl Cyclase Type 5 Inhibition to Treat Myocardial Infarction$673,385
R44 · FY2019 · HL · contact PI
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk$548,580
R01 · FY2019 · HL · contact PI
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk$548,580
R01 · FY2018 · HL · contact PI
Adenylyl Cyclase Type 5 Inhibition to Treat Myocardial Infarction$172,153
R44 · FY2018 · HL · contact PI
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk$548,580
R01 · FY2017 · HL · contact PI
INHIBITION OF ADENYLYL CYCLASE TYPE 5: HEALTHFUL AGING PROTECTION$198,750
R21 · FY2017 · AG · contact PI
SFRP2, cell survival, and coronary vascular angiogenesis$459,618
R01 · FY2016 · HL · contact PI
INHIBITION OF ADENYLYL CYCLASE TYPE 5: HEALTHFUL AGING PROTECTION$238,500
R21 · FY2016 · AG · contact PI
SFRP2, cell survival, and coronary vascular angiogenesis$452,724
R01 · FY2015 · HL · contact PI
AC5 inhibitor for heart failure$856,579
R44 · FY2014 · HL · contact PI
SFRP2, cell survival, and coronary vascular angiogenesis$450,425
R01 · FY2014 · HL · contact PI
Mechanisms of myocardial ischemia and reperfusion$79,500
P01 · FY2014 · HL · contact PI
Rescue of Beta-Adrenergic Cardiomyopathy by Inhibition of Adenylyl Cyclase$41,351
R01 · FY2014 · HL · contact PI
SFRP2, cell survival, and coronary vascular angiogenesis$452,309
R01 · FY2013 · HL · contact PI
Rescue of Beta-Adrenergic Cardiomyopathy by Inhibition of Adenylyl Cyclase$386,100
R01 · FY2012 · HL · contact PI
Pre-emptive conditioning of the ischemic heart$358,437
R01 · FY2012 · HL · contact PI
Rescue of Beta-Adrenergic Cardiomyopathy by Inhibition of Adenylyl Cyclase$104,820
R01 · FY2012 · HL · contact PI
Pre-emptive conditioning of the ischemic heart$27,663
R01 · FY2012 · HL · contact PI
Pre-emptive conditioning of the ischemic heart$390,000
R01 · FY2011 · HL · contact PI
Rescue of Beta-Adrenergic Cardiomyopathy by Inhibition of Adenylyl Cyclase$390,000
R01 · FY2011 · HL · contact PI
Mechanisms of myocardial ischemia and reperfusion$1,966,222
P01 · FY2010 · HL · contact PI
Rescue of Beta-Adrenergic Cardiomyopathy by Inhibition of Adenylyl Cyclase$390,000
R01 · FY2010 · HL · contact PI
Effects of Cardiac Denervation on Ischemic Protection$331,348
P01 · FY2010 · HL · contact PI
Mechanisms of myocardial ischemia and reperfusion$221,501
P01 · FY2010 · HL · contact PI
AC5 Inhibitor for Obesity$133,845
R41 · FY2010 · DK · contact PI
Mechanisms of myocardial ischemia and reperfusion$2,130,497
P01 · FY2009 · HL · contact PI
Rescue of Beta-Adrenergic Cardiomyopathy by Inhibition of Adenylyl Cyclase$390,000
R01 · FY2009 · HL · contact PI
Effects of Cardiac Denervation on Ischemic Protection$323,925
P01 · FY2009 · HL · contact PI
Mechanisms of myocardial ischemia and reperfusion$2,033,433
P01 · FY2008 · HL · contact PI
Effects of Cardiac Denervation on Ischemic Protection$310,382
P01 · FY2008 · HL · contact PI
Age and Gender Differences in Apoptosis and Stem Cells$292,600
R01 · FY2008 · AG · contact PI
Mechanisms of myocardial ischemia and reperfusion$2,020,979
P01 · FY2007 · HL · contact PI
Mechanism of beta blockade therapy in heart failure$478,965
P01 · FY2007 · HL · contact PI
Effects of Cardiac Denervation on Ischemic Protection$319,131
P01 · FY2007 · HL · contact PI
Age and Gender Differences in Apoptosis and Stem Cells$298,571
R01 · FY2007 · AG · contact PI
Mechanisms of myocardial ischemia and reperfusion$2,050,901
P01 · FY2006 · HL · contact PI
Oxidative Stress and ERK Signaling in AC-5 KO Longevity$318,775
R01 · FY2006 · AG · contact PI
Age and Gender Differences in Apoptosis and Stem Cells$307,487
R01 · FY2006 · AG · contact PI
Effects of Cardiac Denervation on Ischemic Protection$294,665
P01 · FY2006 · HL · contact PI
Mechanism of beta blockade therapy in heart failure$220,513
P01 · FY2006 · HL · contact PI
Administrative Core$159,568
P01 · FY2006 · HL · contact PI
Mechanisms of Myocardial Ischemia and Reperfusion$2,299,983
P01 · FY2005 · HL
Genomics in stunned and hibernating myocardium$322,754
P01 · FY2005 · HL
Age and Gender Differences in Apoptosis and Stem Cells$314,888
R01 · FY2005 · AG
Mechanisms of Myocardial Ischemia and Reperfusion$2,236,631
P01 · FY2004 · HL
Age and Gender Differences in Apoptosis and Stem Cells$314,888
R01 · FY2004 · AG
Mechanisms of Myocardial Ischemia and Reperfusion$32,081
P01 · FY2004 · HL
Mechanisms of Myocardial Ischemia and Reperfusion$2,134,423
P01 · FY2003 · HL
TRANSMURAL SR REGULATION IN LV HYPERTROPHY$262,783
R01 · FY2003 · HL
Mechanisms of Myocardial Ischemia and Reperfusion$2,074,703
P01 · FY2002 · HL
Genomics in stunned and hibernating myocardium$296,386
P01 · FY2002 · HL
BETA-ADRENERGIC SIGNALING, DENERVATION AND HEART FAILURE$258,670
R01 · FY2002 · HL
TRANSMURAL SR REGULATION IN LV HYPERTROPHY$256,954
R01 · FY2002 · HL
Mechanisms of Myocardial Ischemia and Reperfusion$2,030,975
P01 · FY2001 · HL
BETA-ADRENERGIC SIGNALING, DENERVATION AND HEART FAILURE$252,960
R01 · FY2001 · HL
TRANSMURAL SR REGULATION IN LV HYPERTROPHY$251,296
R01 · FY2001 · HL
CORE--TISSUE DISTRIBUTION/PATHOLOGY$220,513
P01 · FY2001 · HL
ADRENERGIC AND MAPK SIGNALLING IN HYPERTROPHY AND HEART FAILURE$220,513
P01 · FY2001 · HL
Genomics in stunned and hibernating myocardium$0
P01 · FY2001 · HL
BETA-ADRENERGIC SIGNALING, DENERVATION AND HEART FAILURE$247,418
R01 · FY2000 · HL
TRANSMURAL SR REGULATION IN LV HYPERTROPHY$246,313
R01 · FY2000 · HL
CORE--TISSUE DISTRIBUTION/PATHOLOGY$225,036
P01 · FY2000 · HL
ADRENERGIC AND MAPK SIGNALLING IN HYPERTROPHY AND HEART FAILURE$225,036
P01 · FY2000 · HL